Public research preview
Daniel Goldman, Representative disclosure: Biogen Inc. (BIIB)
Disclosed a sell transaction in Biogen Inc. (BIIB). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
Copy Window
Sandsynligvis for sent
24/100
Signalkvalitet
37/100
Datatillid
93%
high
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 17 Apr 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 42 days
Timeline
Transaction date
6 Mar 2023
Public disclosure
17 Apr 2023
Now
Tracked today
Filing delay: 42 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 10 Jun 2026
Stock path
BIIB from pre-transaction context through latest close.
Transaction
6 Mar 2023 ยท 270,25 USD
- Observed transaction close
- 270,25
- Observed disclosure close
- 292,2
- Observed latest close
- 192,62
- Pre-disclosure move
- +8.1%
- Post-disclosure move
- -34.1%
- Market-adjusted move
- -34.1%
- Pre-disclosure peak run-up
- +8.1%
- Retrace from peak
- 0.0%
Why Copy Window is Probably too late
Supporting factors
- Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 17 Apr 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
FieldExtracted value
roleRepresentative
sidesell
value1001
sourcehouse_stock_act
tickerBIIB
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022653.pdf
personNameDaniel Goldman
amountRange$1,001 - $15,000
companyName3K Biogen Inc. (BIIB)
publishedAt2023-04-17T00:00:00.000Z
rawDocumentIdraw-us-house-20022653-32
disclosureDate2023-04-17
transactionDate2023-03-06
transactionTypeS (partial)